Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In the OASIS 1 trial, subjects receiving oral semaglutide (50 mg) lost 17.4% of their body weight at 68 weeks , while the placebo group achieved only 1.8% weight loss
Mounjaro (tirzepatide) Mounjaro contains tirzepatide, which works on both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors
People Without Obesity [Because] the semaglutide benefit is mostly indirect through control of weight and diabetes, patients without these comorbidities may not receive the same benefits, says Dr
Do not make assumptions about safety Exceeded in-use storage period Discard the pen according to local waste disposal guidelines for sharps and medications Clinical implications of using degraded medication may include inadequate glycaemic control in diabetes management or reduced weight loss efficacy
US$ 28.16
US$ 27.59
US$ 28.45
US$ 22.21
US$ 20.99
US$ 28.39
US$ 29.59
US$ 27.83
